DrugCard

DrugCard is a web-based AI pharmacovigilance platform for pharmacovigilance teams at pharmaceutical companies (MAHs), CROs, and researchers that automates local and global literature monitoring, regulatory intelligence, and adverse event workflows.

Key capabilities include:

• Automated literature screening across 100+ languages and coverage across 45+ countries (website also cites 121+ countries and 2200+ local journals), reducing manual journal review and helping teams capture potential safety signals.
• AI prioritization and summaries, including critical-publication indicators (such as a red man alert) plus auto-generated notes to speed review and triage.
• Regulatory intelligence with real-time updates from 40+ countries, AI summaries, PDF creation, and alerts to support ongoing compliance work.
• Audit-ready traceability and collaboration features such as search logs and QC support to help document screening decisions.

Pricing: Unknown (demo available).

Notable for combining multi-language local literature monitoring with audit-focused traceability. A 2024 Ukraine case study reported reducing article processing time from 11 minutes to 1.5 minutes across 482 journal issues, supporting faster screening without relying on manual cover-to-cover review.